Harvard Bioscience Inc. (HBIO) to Participate in Press Conference Today to Discuss Landmark Surgery  
4/30/2013 2:39:17 PM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HOLLISTON, Mass., April 30, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, will participate in a press conference today at 11:00 a.m. ET regarding its involvement in a landmark surgery that involved materials manufactured by Harvard Apparatus Regenerative Technology, the wholly owned regenerative medicine technology subsidiary of Harvard Bioscience. David Green, Harvard Bioscience's President, will be present and available for questions from the media.

Help employers find you! Check out all the jobs and post your resume.